论文部分内容阅读
目的:研究康艾注射液对胃肠癌化疗患者的生活质量的影响。方法:将42例胃肠癌患者随机分为治疗组(n=22)对照组和(n=20)。治疗组用康艾注射液加化疗,并与单纯化疗组进行对照。观察治疗后的生活质量、评价临床症状改善情况及不良反应。结果:治疗组与对照组疾病控制率分别为91%,30%,KPS提高率分别为59%,30%,Ⅲ°以上不良反应,分别为1例和6例,经比较差异有统计学意义。结论:康艾注射液可改善胃肠癌化疗患者症状,提高生活质量,对化疗有减毒增效的作用。
Objective: To study the effect of Kangai injection on the quality of life of patients with gastrointestinal cancer chemotherapy. Methods: Forty-two patients with gastrointestinal cancer were randomly divided into treatment group (n = 22) and control group (n = 20). The treatment group with Kang Ai injection plus chemotherapy, and chemotherapy alone group were compared. Observe the quality of life after treatment, evaluation of clinical symptoms and adverse reactions. Results: The rates of disease control in the treatment group and the control group were 91% and 30%, respectively. The rates of KPS improvement were 59%, 30% and Ⅲ °, respectively, which were 1 and 6 cases, respectively, with statistically significant differences . Conclusion: Kangai injection can improve the symptoms of patients with gastrointestinal cancer chemotherapy, improve the quality of life, reduce the toxicity of chemotherapy and synergies.